Methyl 2-(1,3-dioxaindan-5-yl)acetate → HCID 136386379, compound
Reaction equation
[NH2:1][C:2]1[N:6]([CH:7]([CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH3:16])[CH2:8][CH2:9][CH3:10])[N:5]=[C:4]([CH2:17][CH3:18])[C:3]=1[C:19]([NH2:21])=[O:20].[CH2:22]1[O:30][C:29]2[CH:28]=[CH:27][C:26]([CH2:31][C:32](OC)=O)=[CH:25][C:24]=2[O:23]1.[O-]CC.[Na+].C(=O)([O-])O.[Na+]>ClCCl>[CH2:22]1[O:30][C:29]2[CH:28]=[CH:27][C:26]([CH2:31][C:32]3[NH:21][C:19](=[O:20])[C:3]4[C:4]([CH2:17][CH3:18])=[N:5][N:6]([CH:7]([CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH3:16])[CH2:8][CH2:9][CH3:10])[C:2]=4[N:1]=3)=[CH:25][C:24]=2[O:23]1Participants
6
Procedure
10 mg (0.034 mmol) of 5-amino-3-ethyl-1-(4-decyl)-1H-pyrazole-4-carboxamide and 20 mg (0.103 mmol) of methyl 3,4-methylenedioxyphenylacetate are refluxed for 6 hours in 0.3 ml of a 0.5M ethanolic sodium ethoxide solution. After dichloromethane and saturated aqueous sodium hydrogen carbonate solution have been added, the phases are separated. Purification by chromatography gives 4 mg (48%) of a solid, Rf=0.68 (dichloromethane/methanol=15:1).
Workup
- customthe phases are separated
- customPurification by chromatography
Sources & evidence
- ORD record
- ord-14712aeb30a945eeb68947ac17d00005
- Source dataset
- uspto-grants-2001_01
- Patent number
- US06174884B1
Reaction notes
Loading…